Blood-Brain Barrier Conquest in Glioblastoma Nanomedicine: Strategies, Clinical Advances, and Emerging Challenges
Preprint
- 3 September 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Glioblastoma (GBM) is a prevalent type of malignancy within the central nervous system (CNS), associated with a poor prognosis. The standard treatment for GBM includes surgical resection of the tumor, followed by radiotherapy and chemotherapy; yet despite these interventions, overall treatment outcomes remain suboptimal. The blood-brain barrier (BBB), which plays a crucial role in maintaining the stability of brain tissue under normal physiological conditions of the CNS,also poses a significant obstacle to the effective delivery of therapeutic agents to GBM. Recent preclinical studies have demonstrated that nanomedicine delivery systems (NDDS) offer promising results, demonstrating both effective GBM targeting and safety, thereby presenting a potential solution for targeted drug delivery. This review explores the various strategies employed in preclinical studies to overcome the BBB for drug delivery. Subsequently, the results of clinical translation of NDDS has been summarized, highlighting the progress made. Finally, we discuss potential strategies for advancing NDDS development and accelerating their translational research through well-designed clinical trials in GBM therapy.Keywords
All Related Versions
- Version 1, 2024-09-03, Preprints
- Published version: Cancers, 16 (19), 3300.
This publication has 143 references indexed in Scilit:
- Efficient Delivery of Lomitapide using Hybrid Membrane‐Coated Tetrahedral DNA Nanostructures for Glioblastoma TherapyAdvanced Materials, 2024
- Drug Repurposing‐Based Brain‐Targeting Self‐Assembly Nanoplatform Using Enhanced Ferroptosis against GlioblastomaSmall, 2023
- Nanoparticles Mediated the Diagnosis and Therapy of Glioblastoma: Bypass or Cross the Blood–Brain BarrierSmall, 2023
- Hsp70‐Targeting and Size‐Tunable Nanoparticles Combine with PD‐1 Checkpoint Blockade to Treat GliomaSmall, 2023
- Polyhedral Oligomeric Silsesquioxane‐Based Nanoparticles for Efficient Chemotherapy of GlioblastomaSmall, 2023
- Systemic Brain Delivery of Antisense Oligonucleotides across the Blood–Brain Barrier with a Glucose‐Coated Polymeric NanocarrierAngewandte Chemie International Edition, 2020
- Effective and Targeted Human Orthotopic Glioblastoma Xenograft Therapy via a Multifunctional Biomimetic NanomedicineAdvanced Materials, 2018
- Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer NanomedicinesAdvanced Healthcare Materials, 2017
- A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomaCancer Chemotherapy and Pharmacology, 2017
- Choline‐Derivate‐Modified Nanoparticles for Brain‐Targeting Gene DeliveryAdvanced Materials, 2011